Thermo Fisher Agrees to Acquire Sanofi’s Steriles Manufacturing Site
Thermo Fisher will expand use of the Sanofi site to meet the demand from pharma and biotech customers for U.S. manufacturing capacity.
Related Articles
RNA Expands Its Clinical Clout
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
Cell-Free Heart Attack Meds Viewed as Easy-to-Make Alternative to Cell Therapies
The concept of using proteins and other secreted factors to treat heart attack, rather than replacement cells, has emerged.
Getting End-to-End Digital Twins to Work Harder
Researchers focus on generating the best possible model from the types of manufacturing data available.
Miniaturization with Bioreactor Levitation
Researchers developed a benchtop bioreactor that can handle mL to liters. Instead of a shaft-driven stirrer, this bioreactor uses levitation.
Scientists identify culprit behind biggest ever U.S. honey bee die-off
USDA research points to viruses spread by pesticide-resistant mites, indicating a worrying trend
Quantum computers made of individual atoms leap to the fore
After decades in the doldrums, atom-based machines could overtake rival technologies
A Study Has Revealed The Biggest Risk Factors For Getting Early Dementia, And Knowledge Is Power
Genetics is only one piece of the puzzle.
Contents | Science 365, 6450
COVER Neil Armstrong’s shadow cast on the surface of the Moon. This image was taken by Armstrong on 21 July 1969, as part of a…
Consortium Aims to Deliver Fully-Automated Robotics CGT Manufacturing Platform
The CGT sector is currently only capable of manufacturing sufficient doses to treat less than 7% of eligible patients globally.
The U.S. Is Testing Tiny Nuclear Reactors That Can Go Practically Anywhere
Compact, energy-efficient microreactors could soon help generate electricity for remote locations.
